Published in J Mol Neurosci on June 01, 2002
Therapies for human prion diseases. Am J Neurodegener Dis (2013) 0.85
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol (2009) 1.94
Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet (2005) 1.82
Novel methods for disinfection of prion-contaminated medical devices. Lancet (2004) 1.68
Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J Immunol (2002) 1.65
In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog (2007) 1.56
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS One (2008) 1.56
Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat Biotechnol (2003) 1.45
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine (2004) 1.36
PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease. J Virol (2005) 1.33
Extracellular NAD and ATP: Partners in immune cell modulation. Purinergic Signal (2007) 1.26
The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep (2003) 1.23
Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion (2002) 1.18
ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site. FASEB J (2007) 1.16
Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med (2010) 1.13
CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins. J Immunol (2005) 1.12
Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res (2004) 1.10
ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages. Antivir Ther (2004) 1.10
NAD+ and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells. J Immunol (2009) 1.09
Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay. PLoS One (2009) 1.08
Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am J Pathol (2005) 1.07
Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia (2003) 1.01
NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J Immunol (2007) 1.00
Impact of bone marrow hematopoiesis failure on T-cell generation during pathogenic simian immunodeficiency virus infection in macaques. Blood (2004) 0.99
Investigations of a prion infectivity assay to evaluate methods of decontamination. J Microbiol Methods (2007) 0.99
Hydrolysis of the amyloid prion protein and nonpathogenic meat and bone meal by anaerobic thermophilic prokaryotes and streptomyces subspecies. J Agric Food Chem (2004) 0.96
HIV type 1 diversity in France, 1999-2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs. AIDS Res Hum Retroviruses (2003) 0.96
Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells. J Immunol (2009) 0.95
Lipopolysaccharide, IFN-gamma, and IFN-beta induce expression of the thiol-sensitive ART2.1 Ecto-ADP-ribosyltransferase in murine macrophages. J Immunol (2007) 0.94
Characterization of human monocyte-derived microglia-like cells. Glia (2006) 0.93
Role of gut macrophages in mice orally contaminated with scrapie or BSE. Int J Pharm (2005) 0.93
A novel generation of heparan sulfate mimetics for the treatment of prion diseases. J Gen Virol (2003) 0.93
Time-course studies of 14-3-3 protein isoforms in cerebrospinal fluid and brain of primates after oral or intracerebral infection with bovine spongiform encephalopathy agent. J Gen Virol (2007) 0.92
PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C R Biol (2002) 0.92
Nonnucleoside inhibitors of HIV-1 reverse transcriptase: from the biology of reverse transcription to molecular design. Curr Top Med Chem (2003) 0.91
Probing the expression and function of the P2X7 purinoceptor with antibodies raised by genetic immunization. Cell Immunol (2005) 0.91
ADP-ribosylation of membrane proteins: unveiling the secrets of a crucial regulatory mechanism in mammalian cells. Ann Med (2006) 0.90
Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions. Transfusion (2011) 0.89
Genetic determinants of acute inflammation regulate Salmonella infection and modulate Slc11a1 gene (formerly Nramp1) effects in selected mouse lines. Microbes Infect (2006) 0.89
High incidence of scrapie induced by repeated injections of subinfectious prion doses. J Virol (2005) 0.89
Modulation of indoleamine-2,3-dioxygenase expression and activity by HIV-1 in human macrophages. Fundam Clin Pharmacol (2009) 0.89
Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J Gen Virol (2004) 0.88
Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice. Mol Cell Biol (2002) 0.88
Common occurrence of zoonotic pathogen Cryptosporidium meleagridis in broiler chickens and turkeys in Algeria. Vet Parasitol (2013) 0.88
Convergent alteration of granulopoiesis, chemotactic activity, and neutrophil apoptosis during mouse selection for high acute inflammatory response. J Leukoc Biol (2003) 0.87
T cells of different developmental stages differ in sensitivity to apoptosis induced by extracellular NAD. Dev Immunol (2002) 0.86
Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines. J Virol (2003) 0.86
Using budding yeast to screen for anti-prion drugs. Biotechnol J (2006) 0.86
Simultaneous measurement of kynurenine and tryptophan in human plasma and supernatants of cultured human cells by HPLC with coulometric detection. Clin Chem (2004) 0.86
Activation of the P2X7 ion channel by soluble and covalently bound ligands. Purinergic Signal (2009) 0.86
Differential regulation of gelatinase A and B and TIMP-1 and -2 by TNFalpha and HIV virions in astrocytes. Microbes Infect (2004) 0.85
Size distribution dependence of prion aggregates infectivity. Math Biosci (2008) 0.85
Inverse genetic predisposition to colon versus lung carcinogenesis in mouse lines selected based on acute inflammatory responsiveness. Carcinogenesis (2006) 0.84
Inhibition of HIV-1 replication by cell-penetrating peptides binding Rev. J Biol Chem (2003) 0.84
Up-regulation of glutamate concentration in the putamen and in the prefrontal cortex of asymptomatic SIVmac251-infected macaques without major brain involvement. J Neurochem (2004) 0.84
Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation. Purinergic Signal (2007) 0.83
BSE infection of the small short-lived primate Microcebus murinus. C R Biol (2002) 0.83
Synthesis of prenyl pyrophosphonates as new potent phosphoantigens inducing selective activation of human Vgamma9Vdelta2 T lymphocytes. J Med Chem (2004) 0.82
Expression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia? J Neuropathol Exp Neurol (2003) 0.81
Dual conformation of H2H3 domain of prion protein in mammalian cells. J Biol Chem (2011) 0.81
Genetic control of IL-1 beta production and inflammatory response by the mouse Irm1 locus. J Immunol (2010) 0.81
BSE and variant Creutzfeldt-Jakob disease: never say never. Acta Neuropathol (2002) 0.81
Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA. Virulence (2015) 0.81
Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases. J Gen Virol (2007) 0.81
A biased Valpha24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease. Immunol Lett (2003) 0.81
Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-tau in human macrophages. Int Immunol (2005) 0.80
Structure-activity studies of heparan mimetic polyanions for anti-prion therapies. Biochem Biophys Res Commun (2007) 0.80
Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases. J Neuropathol Exp Neurol (2004) 0.80
Regulated expression of sodium-dependent glutamate transporters and synthetase: a neuroprotective role for activated microglia and macrophages in HIV infection? Brain Pathol (2003) 0.80
Differential expression levels of MRP1, MRP4, and MRP5 in response to human immunodeficiency virus infection in human macrophages. Antimicrob Agents Chemother (2004) 0.80
Different isoforms of the non-integrin laminin receptor are present in mouse brain and bind PrP. Biol Chem (2003) 0.80
Differences in the activation of the GFAP gene promoter by prion and viral infections. Brain Res Mol Brain Res (2002) 0.79
Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7. Purinergic Signal (2009) 0.79
Comparative effects of two type I interferons, human IFN-alpha and ovine IFN-tau on indoleamine-2,3-dioxygenase in primary cultures of human macrophages. Fundam Clin Pharmacol (2007) 0.79
Knock-down of the 37-kDa/67-kDa laminin receptor in mouse brain by transgenic expression of specific antisense LRP RNA. Transgenic Res (2004) 0.79
Involvement of macrophages in the pathogenesis of transmissible spongiform encephalopathies. Dev Immunol (2002) 0.79
Blood reference materials from macaques infected with variant Creutzfeldt-Jakob disease agent. Transfusion (2014) 0.79
Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity. J Med Chem (2004) 0.78
Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251. Retrovirology (2004) 0.78
Ultrastructural evidence that ependymal cells are infected in experimental scrapie. Acta Neuropathol (2008) 0.78
The expression of P-glycoprotein and cellular kinases is modulated at the transcriptional level by infection and highly active antiretroviral therapy in a primate model of AIDS. AIDS Res Hum Retroviruses (2003) 0.78
Synthesis and biological evaluation in human monocyte-derived macrophages of N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine analogues with potent antioxidant and anti-HIV activities. J Med Chem (2004) 0.78
New inhibitors of prion replication that target the amyloid precursor. J Gen Virol (2009) 0.78
Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice. Prion (2007) 0.78
Glycosylation-related gene expression in prion diseases: PrPSc accumulation in scrapie infected GT1 cells depends on beta-1,4-linked GalNAc-4-SO4 hyposulfation. J Biol Chem (2005) 0.78
Cutting edge: CD4-independent development of functional FoxP3+ regulatory T cells. J Immunol (2009) 0.78